Androgen Receptors and Keloid Treatment in Children: Insights on Androgen Insensitivity Syndrome
DOI:
https://doi.org/10.52783/jns.v14.1646Keywords:
keloid, steroid, corticosteroid, botulinum toxin type A, Androgen Insensitivity SyndromeAbstract
Background: Keloids can form from an overgrowth of skin fibroblasts where the scar tissue extends beyond the initial boundaries of the injury; they are benign lesions. Studies indicated that androgens could influence these fibroblasts to cause excessive collagen deposition causing keloid formation (1). We aim to look at surgical and non-surgical management of keloids in children and to explore pain management during keloid treatment in children.
Methods: A systematic search was conducted using Medline, Embase, PubMed and Cochrane Library looking into the different keloid treatments used in children. As there were limited studies looking into pain management in children, an exclusion was made to investigate adult (age>18 years) studies. We hypothesized that the use of surgical and adjuvant therapy is better for steroid treatment.
Results: Out of the 33 abstracts, 21 articles fit the inclusion criteria.
Conclusion: Non-surgical treatments such as intralesional triamcinolone acetonide (TCA) and Botulinum toxin Type A reduced the volume of keloids up to around 80%. A combination therapy is safer with fewer side effects in the paediatric population. A study has also suggested the use of anti-androgenic treatment such as Finasteride or Combined Oral Contraceptives can help to reduce inflammation within the skin and provide ‘long-term’ health benefits to those predisposed to keloids. Surgical and non- surgical treatment
(including anti-androgenic treatment) may be used in those who develop keloids after
gender affirming surgeries in those with conditions such as Androgen Insensitivity Syndrome (2). Further studies are required to understand the multimodal therapy that can be used to treat keloids in children.
Downloads
Metrics
References
Yang Y, Chen Z, Wu X, Liu W, Gao Z. Androgen-related disorders and hormone therapy for patients with keloids. Chinese Journal of Plastic and Reconstructive Surgery. 2022;4(1):44-8.
Alyami F, Ferandez N, Koyle MA, Salle JP. Keloid formation after pediatric male genital surgeries: an uncommon and difficult problem to manage. Journal of Pediatric Urology 2019;15(1):48.e1-.e8.
Bonnardeaux E, McCuaig C. Surgical excision combined with fully ablative carbon dioxide laser therapy and triamcinolone injections as a potential treatment for keloids in children. Pediatr Dermatol. 2020;37(1):137-41.
Ramirez-Fort MK, Meier B, Feily A, Cooper SL, Lange CS. Adjuvant irradiation to prevent keloidal fibroproliferative growth should be standard of care. Br J Dermatol. 2017;177(6):e327-e8. 5.
Polo M, Smith PDC, Kim YJ, Wang X, Ko F, Robson MC. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics. Annals of plastic surgery. 1999;43 2:185-90.
Park TH, Chang CH. Location of Keloids and Its Treatment Modality May Influence the Keloid Recurrence in Children. J Craniofac Surg. 2015;26(4):1355-7.
Ogawa R. The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids A 2020 Update of the Algorithms Published 10 Years Ago. Plast Reconstr Surg. 2022;149(1):79e-94e.
Liu XG, Zhang D. Evaluation of Efficacy of Corticosteroid and Corticosteroid Combined with Botulinum Toxin Type A in the Treatment of Keloid and Hypertrophic Scars: A Meta-Analysis. Aesthetic Plast Surg. 2021;45(6):3037-44.
Khan FA, Drucker NA, Larson SD, Taylor JA, Islam S. Pediatric earlobe keloids: Outcomes and patterns of recurrence. J Pediatr Surg. 2020;55(3):461-4.
Wang X, Wu X, Liu K, Xia L, Lin X, Liu W, et al. Topical cryoanesthesia for the relief of pain caused by steroid injections used to treat hypertrophic scars and keloids. Medicine (Baltimore). 2017;96(43):e8353.
Kouotou EA NJ, Omona Guissana E, et al. Epidemiology and clinical features of keloids in Black Africans: a nested case-control study from Yaound e,
Cameroon. Int J Dermatol. 2019:1135-40.
Yagi KI DA, Osman AA. Does an immune reaction to sebum in wounds cause keloid scars? Beneficial effect of desensitisation. Br J Plast Surg. 1979:223–5.
Shaarawy E, Hegazy RA, Abdel Hay RM. Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial. J Cosmet Dermatol. 2015;14(2):161-6.
Acosta S, Ureta E, Yañez R, Oliva N, Searle S, Guerra C. Effectiveness of Intralesional Triamcinolone in the Treatment of Keloids in Children. Pediatr Dermatol. 2016;33(1):75-9.
Ogawa R, Yoshitatsu S, Yoshida K, Miyashita T. Is radiation therapy for keloids acceptable? The risk of radiation-induced carcinogenesis. Plast Reconstr Surg. 2009;124(4):1196-201.
Leszczynski R, da Silva CA, Pinto A, Kuczynski U, da Silva EM. Laser therapy for treating hypertrophic and keloid scars. Cochrane Database Syst Rev. 2022;9(9):Cd011642.
Usanakornkul A, Burusapat C. A Topical Anesthetic and Lidocaine Mixture for Pain Relief During Keloid Treatment: A Double-Blind, Randomized Controlled Trial. Dermatol Surg. 2017;43(1):66-73.
Secil A, Fatih C, Gokhan A, Alpaslan GF, Gonul SR. Efficacy of vibration on venipuncture pain scores in a pediatric emergency department. Pediatr Emerg Care. 2014;30(10):686-8.
Bourdier S, Khelif N, Velasquez M, Usclade A, Rochette E, Pereira B, et al. Cold Vibration (Buzzy) Versus Anesthetic Patch (EMLA) for Pain Prevention During Cannulation in Children: A Randomized Trial. Pediatr Emerg Care. 2021;37(2):86-91.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
